![](/img/cover-not-exists.png)
913 USING SHORT-TERM MONOTHERAPY AND IN VITRO DATA TO MAKE EARLY PREDICTIONS OF CLINICAL HCV RESPONSE: EXAMPLES FROM MK-5172, A SECOND GENERATION HCV NS3/4A PROTEASE INHIBITOR
R.B. Nachbar, J.A. Stone, A. Petry, B. Poland, L. Caro, L.A. Wenning, A. Khan, J. Palcza, K. Van Dyck, I. Fraser, N. Mobashery, E. O'MaraVolume:
56
Year:
2012
Language:
english
DOI:
10.1016/s0168-8278(12)60925-8
File:
PDF, 76 KB
english, 2012